Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,123 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 4,603 · Balance 19,123 F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date August 05, 2025 · Filed August 05, 2025
Section 16 reporting ended · disclosed 2025-08-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 9,802 |
Reported balance
Holding disclosure · report date 2025-08-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 9,802 F1: Mr. Ghoshal is no longer subject to reporting due to termination as of August 1, 2025. |
| ResMed Common StockSEC Table I · non-derivative | IndirectKaushik Ghoshal and Jayati Ghoshal Family Trust | 9,628 |
Reported balance
Holding disclosure · report date 2025-08-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,628 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Ghoshal is no longer subject to reporting due to termination as of August 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 4,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001881922-26-000002 · form4-06032026_040607.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,123 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:12 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015380 · form4-06032025_080659.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,520 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the one-year anniversary of the grant date. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,589 | $0.00 Strike: $146.34 | $0.00 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · derivative · entry 10 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 3,589 shares Expires 2026-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,882 | $0.00 Strike: $211.76 | $0.00 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · derivative · entry 9 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 5,882 shares Expires 2027-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 105 | $0.00 Strike: $211.76 | $0.00 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · derivative · entry 8 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 105 shares Expires 2027-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 169 | $0.00 Strike: $146.34 | $0.00 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · derivative · entry 7 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 169 shares Expires 2026-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 9,745 | $239.31 | $2,332,096.41 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · nonDerivative · entry 5 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,725 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $236.62 - $242.73. The price reported above reflects the weighted average sale price. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,882 | $211.76 | $1,245,572.32 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · nonDerivative · entry 4 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,589 | $146.34 | $525,214.26 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · nonDerivative · entry 3 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 105 | $211.76 | $22,234.80 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:19 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 169 | $146.34 | $24,731.46 |
DisclosureSEC source: 0001127602-25-009051 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 4,726 | $0.00 Strike: $211.76 | $0.00 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · derivative · entry 12 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,882 Underlying: ResMed Common Stock · 4,726 shares Expires 2027-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 514 | $0.00 Strike: $146.34 | $0.00 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · derivative · entry 11 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169 Underlying: ResMed Common Stock · 514 shares Expires 2026-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,506 | $0.00 Strike: $146.34 | $0.00 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · derivative · entry 10 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,589 Underlying: ResMed Common Stock · 3,506 shares Expires 2026-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 367 | $0.00 Strike: $211.76 | $0.00 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · derivative · entry 9 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105 Underlying: ResMed Common Stock · 367 shares Expires 2027-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 per year. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 4,726 | $235.43 | $1,112,623.75 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 8 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,725 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 514 | $235.25 | $120,917.78 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 7 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,451 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,506 | $235.40 | $825,308.19 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 6 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,965 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 367 | $235.25 | $86,336.24 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 5 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,471 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $235.00 - $236.18. The price reported above reflects the weighted average sale price. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 4,726 | $211.76 | $1,000,777.76 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 4 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 514 | $146.34 | $75,218.76 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 3 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,506 | $146.34 | $513,068.04 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 367 | $211.76 | $77,715.92 |
DisclosureSEC source: 0001127602-25-007977 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2024. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:25 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,417.925 | $252.38 | $357,855.91 |
DisclosureSEC source: 0001127602-24-027070 · form4.xml · nonDerivative · entry 3 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,725 F3 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:25 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 445.588 | $252.38 | $112,457.50 |
DisclosureSEC source: 0001127602-24-027070 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,142 F2 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:25 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 603.075 | $252.38 | $152,204.07 |
DisclosureSEC source: 0001127602-24-027070 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,588 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021. Read SEC document |
| October 30, 2024 Filed Nov 2, 2024 00:07 UTC | RESMED INC RMD · Entity 2692 | OtherResMed Common Stock | 9,628.096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026257 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: No plan indicated Ownership: Indirect · Kaushik Ghoshal and Jayati Ghoshal Family Trust Disclosed balance after: 9,628 Read SEC document |
| October 30, 2024 Filed Nov 2, 2024 00:07 UTC | RESMED INC RMD · Entity 2692 | OtherResMed Common Stock | 9,628.096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-026257 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,160 F1 · kind: Transfer of shares from direct holdings to the Kaushik Ghoshal and Jayati Ghoshal Family Trust. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 14:06 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 4,260 | $0.00 Strike: $101.64 | $0.00 |
DisclosureSEC source: 0001127602-24-025433 · form4.xml · derivative · entry 3 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 4,260 shares Expires 2025-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 14:06 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 4,260 | $238.48 | $1,015,924.80 |
DisclosureSEC source: 0001127602-24-025433 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,788 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 14:06 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 4,260 | $101.64 | $432,986.40 |
DisclosureSEC source: 0001127602-24-025433 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:54 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,000 | $0.00 Strike: $101.64 | $0.00 |
DisclosureSEC source: 0001127602-24-023884 · form4.xml · derivative · entry 3 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,260 Underlying: ResMed Common Stock · 5,000 shares Expires 2025-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:54 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,000 | $252.56 | $1,262,800.00 |
DisclosureSEC source: 0001127602-24-023884 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,788 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:54 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,000 | $101.64 | $508,200.00 |
DisclosureSEC source: 0001127602-24-023884 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Chief Commercial Officer, SaaS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 14:14 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 841 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022296 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,788 F2 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthe grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 14:14 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022296 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,947 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3each year on the anniversary of the grant. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 1,037 | $0.00 Strike: $101.64 | $0.00 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · derivative · entry 7 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,260 Underlying: ResMed Common Stock · 1,037 shares Expires 2025-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 6,877 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · derivative · entry 6 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 6,877 shares Expires 2025-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,086 | $0.00 Strike: $95.80 | $0.00 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · derivative · entry 5 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 2,086 shares Expires 2025-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 10,000 | $216.60 | $2,166,000.00 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 4 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,032 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 1,037 | $101.64 | $105,400.68 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 3 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 6,877 | $95.80 | $658,816.60 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 19:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,086 | $95.80 | $199,838.80 |
DisclosureSEC source: 0001127602-24-022064 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:24 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 5,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-014255 · form4-05232024_080508.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,119 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders. Read SEC document |
| November 20, 2023 Filed Nov 20, 2023 22:21 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 366.971 | $148.94 | $54,656.66 |
DisclosureSEC source: 0001127602-23-028012 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,908 F1 · kind: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:28 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 435.943 | $143.60 | $62,601.41 |
DisclosureSEC source: 0001127602-23-027467 · form4.xml · nonDerivative · entry 2 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,275 F2 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022. F3 · balance_after: Includes 28.354 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:28 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 590.733 | $143.60 | $84,829.26 |
DisclosureSEC source: 0001127602-23-027467 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,711 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 17:06 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022929 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,273 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:05 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 2,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011558 · form4-07282023_080717.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,402 F1 · shares: Grant of restricted shares, under the Issuer's equity incentive plan, in consideration of services as a Board member, pursuant to the Issuer's Board of Directors Compensation Plan. Shares shall vest in full on the date of the Issuer's 2024 Annual Meeting of Stockholders. Read SEC document |
| July 13, 2023 Filed Jul 14, 2023 16:26 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 500 | $220.00 | $110,000.00 |
DisclosureSEC source: 0001127602-23-020719 · form4.xml · nonDerivative · entry 1 Ghoshal Kaushik · CIK 0001881922 · President, SaaS Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,787 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 17, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.